Is There an Ethical Obligation to Disclose Controversial Risk? A Question From the ACCORD Trial

American Journal of Bioethics 14 (4):4-10 (2014)
  Copy   BIBTEX

Abstract

Researchers designing a clinical trial may be aware of disputed evidence of serious risks from previous studies. These researchers must decide whether and how to describe these risks in their model informed consent document. They have an ethical obligation to provide fully informed consent, but does this obligation include notice of controversial evidence? With ACCORD as an example, we describe a framework and criteria that make clear the conditions requiring inclusion of important controversial risks. The ACCORD model consent document did not include notice of prior trials with excess death. We develop and explain a new standard labeled risk in equipoise. We argue that our approach provides an optimal level of integrity to protect the informational needs of the reasonable volunteers who agree to participate in clinical trials. We suggest language to be used in a model consent document and the informed consent discussion when such controversial evidence exists

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,075

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Valuing risk: The ethical review of clinical trial safety.Jonathan Kimmelman - 2004 - Kennedy Institute of Ethics Journal 14 (4):369-393.
The ethics of experimental heroin maintenance.R. Ostini, G. Bammer, P. R. Dance & R. E. Goodin - 1993 - Journal of Medical Ethics 19 (3):175-182.

Analytics

Added to PP
2014-04-15

Downloads
25 (#634,233)

6 months
8 (#362,756)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Joseph DeMarco
Cleveland State University

References found in this work

No references found.

Add more references